Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Lemaire, K" or (type any "bookEditor journalEditor issueEditor" and editor="Lemaire, K")

Add to list
- Conference Paper
- C3
Mucosal gene expression profiling differentiates early from late ileal Crohn's disease

I Arijs, L Van Lommel, G De Hertogh, K Machiels, K Lemaire, Kristel Van Steen (UGent) , GA Van Assche, S Vermeire, FC Schuit and PJ Rutgeens

(2011) GASTROENTEROLOGY. 140(5, suppl. 1). p.S270-S270
Add to list
- Journal Article
- A1
Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment

I Arijs, G De Hertogh, K Machiels, Kristel Van Steen (UGent) , K Lemaire, A Schraenen, L Van Lommel, R Quintens, G Van Assche, S Vermeire, et al.

(2011) AMERICAN JOURNAL OF GASTROENTEROLOGY. 106(4). p.748-761
Add to list
- Journal Article
- A1
Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease

I Arijs, R Quintens, L Van Lommel, Kristel Van Steen (UGent) , G De Hertogh, K Lemaire, A Schraenen, C Perrier, G Van Assche, S Vermeire, et al.

(2010) INFLAMMATORY BOWEL DISEASES. 16(12). p.2090-2098
Add to list
- Journal Article
- A1
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

I Arijs, K Li, G Toedter, R Quintens, L Van Lommel, Kristel Van Steen (UGent) , P Leemans, G De Hertogh, K Lemaire, M Ferrante, et al.

(2009) GUT. 58(12). p.1612-1619
Add to list
- Conference Paper
- C3
Microarray study of mucosal antimicrobial peptides in patients with inflammatory bowel disease before and after first infliximab treatment

I Arijs, L Van Lommel, Kristel Van Steen (UGent) , G De Hertogh, R Quintens, K Lemaire, Marie Joossens (UGent) , FC Schuit, K Geboes, GA Van Assche, et al.

(2008) GASTROENTEROLOGY. 134(4, suppl. 1). p.A457-A457
Add to list
- Journal Article
- A1
A gene encoding a sphingolipid biosynthesis enzyme determines the sensitivity of Saccharomyces cerevisiae to an antifungal plant defensin from dahlia (Dahlia merckii).

K THEVISSEN, BPA CAMMUE, K LEMAIRE, J WINDERICKX, RC DICKSON, RL LESTER, KKA FERKET, F VAN EVEN, AHA PARRET and WF BROEKAERT

(2000) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 97(17). p.9531-9536

Academic Bibliography

Mucosal gene expression profiling differentiates early from late ileal Crohn's disease

Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment

Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

Microarray study of mucosal antimicrobial peptides in patients with inflammatory bowel disease before and after first infliximab treatment

A gene encoding a sphingolipid biosynthesis enzyme determines the sensitivity of Saccharomyces cerevisiae to an antifungal plant defensin from dahlia (Dahlia merckii).

Contents

Support

Contact